Trajectories of long‐term survival after status epilepticus
The optimal time point to assess survival in the acute phase is at 6 months, whereas evaluating survival after 2.5 years provides reliable estimates of long-term mortality. Assessing SE survival at discharge underestimates the impact of remote symptomatic etiologies and duration of SE on long-term survival.
Authors
- Susanne Knake (ORCID: https://orcid.org/0000-0002-6298-0513)
- Line Bédos Ulvin (ORCID: https://orcid.org/0000-0003-0589-4931)
- Camilla Dyremose Cornwall (ORCID: https://orcid.org/0000-0001-8814-3695)
- Erik Taubøll (ORCID: https://orcid.org/0000-0001-7208-7932)
- Felix Rosenow
- Adam Strzelczyk (ORCID: https://orcid.org/0000-0001-6288-9915)
- Christoph P. Beier (ORCID: https://orcid.org/0000-0001-8268-1492)
- Kjell Heuser (ORCID: https://orcid.org/0000-0003-2057-694X)
- Simon Bang Kristensen (ORCID: https://orcid.org/0000-0002-5533-6922)
Institutions
- Goethe University Frankfurt (DE)
- Oslo University Hospital (NO)
- Philipps University of Marburg (DE)
- University of Southern Denmark (DK)
- University of Oslo (NO)
- Aarhus University (DK)
- Odense University Hospital (DK)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1111/epi.18428
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Lundbeckfonden
- H. Lundbeck A/S